Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare multiple congenital anomalies syndrome characterized by facial dysmorphism (hypertelorism, broad and high nasal bridge, depressed nasal ridge, short columella, underdeveloped maxilla, and prominent cupid-bow upper lip vermillion), mild to severe congenital sensorineural hearing loss, and skeletal abnormalities consisting of brachytelephalangy and broad thumbs and halluces with large, rounded epiphyses. Additional manifestations that have been reported include pulmonary valve stenosis, voice hoarseness and renal agenesis.
Features include always present findings: Hypertelorism and Wide nose; and very common findings: Intellectual disability. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Strabismus, Unilateral ptosis |
Arms and legs |
GPC4 encodes glypican 4 (556 aa). Cell surface proteoglycan that bears heparan sulfate. May be involved in the development of kidney tubules and of the central nervous system Highest expression in Esophagus Muscularis (65.5 TPM) and Esophagus Gastroesophageal Junction (59.2 TPM).
Keipert syndrome is associated with mutations in the GPC4 gene on chromosome X.
GPC4 is classified as a druggable target (Cell Surface, Druggable Genome, and External Side Of Plasma Membrane categories) with score 4.4.
Genetic testing for GPC4 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 1 very common feature, 12 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Keipert syndrome.
4 publications have been identified in PubMed for Keipert syndrome. Research spans Review / Meta-Analysis (50%) and Case Report / Case Series (50%).
Bolat H (2026). [PMID: 41708914](https://pubmed.ncbi.nlm.nih.gov/41708914/). *Neurol Sci*. [Case Report / Case Series]
Lazea C (2024). [PMID: 38791606](https://pubmed.ncbi.nlm.nih.gov/38791606/). *Int J Mol Sci*. [Review / Meta-Analysis]
Ouidja MO (2024). [PMID: 39630030](https://pubmed.ncbi.nlm.nih.gov/39630030/). *Essays Biochem*. [Review / Meta-Analysis]
Kuroda Y (2024). [PMID: 38923342](https://pubmed.ncbi.nlm.nih.gov/38923342/). *Am J Med Genet A*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 8:54 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Keipert syndrome
2 |
Absent toenail, Broad distal phalanx of finger |
Head and neck | 2 | Macrocephaly, Thick upper lip vermilion |
Bones and joints | 1 | Joint hypermobility |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Brain and nerves | 1 | Intellectual disability |